Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses

Breast cancer (BC) is the most common cancer globally, accounting for 685,000 deaths in 2020. Triple-negative breast cancers (TNBC) lack oestrogen (ER) and progesterone (PR) hormone receptor expression and HER2 overexpression. TNBC represent 10–15% of all BC with high incidence in women under 50-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Green-Tripp, Gabriela, Nattress, Callum, Halldén, Gunnel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263221/
https://www.ncbi.nlm.nih.gov/pubmed/35813830
http://dx.doi.org/10.3389/fmolb.2022.901392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263221/
https://www.ncbi.nlm.nih.gov/pubmed/35813830
http://dx.doi.org/10.3389/fmolb.2022.901392

Ejemplares similares